Skip to main content
AXGN
NASDAQ Industrial Applications And Services

Axogen Finalizes $124M Common Stock Offering at Discount, Repays Credit Facility

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$32
Mkt Cap
$1.476B
52W Low
$9.215
52W High
$34.705
52W Position info
247% above low
Off High info
7.8% below high
Rel. Volume info
3.5× avg
Market data snapshot near publication time

AXGN has more than doubled off its 52-week low of $9.215 on elevated volume (3.5× avg).

Summary

Axogen, Inc. finalized an underwritten public offering of 4 million shares of common stock at $31.00 per share, raising $124 million, with an option for an additional $18.6 million, primarily to repay its credit facility.


Key Events · Financing and Capital Events · AXGN

  • Finalizes Common Stock Offering

    Axogen finalized an underwritten public offering of 4,000,000 shares of common stock at $31.00 per share, raising $124 million.

  • Underwriters' Over-Allotment Option

    Underwriters have a 30-day option to purchase an additional 600,000 shares, potentially increasing total proceeds by $18.6 million.

  • Strategic Debt Repayment

    Approximately $69.7 million of the net proceeds will be used for the early payoff and termination of the company's credit facility.

  • Share Dilution

    The offering, priced at a discount to recent market prices, will result in immediate and substantial dilution for existing shareholders.


Analysis · AXGN · Industrial Applications And Services

This 424B5 filing finalizes the terms and pricing of a significant common stock offering, which was initiated on January 21, 2026. The offering of 4 million shares at $31.00 per share, with an additional 600,000 shares option, could raise up to $142.6 million. This represents a substantial capital raise, leading to nearly 10% dilution for existing shareholders. A significant portion of the net proceeds, approximately $69.7 million, is allocated for the early payoff and termination of the company's credit facility, which is a positive step for balance sheet health and reducing financial risk. The offering price of $31.00 per share is at a discount to the last reported sale price of $33.01 on January 21, 2026, and today's price of $32.00.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AXGN was trading at $32.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $9.22 to $34.71. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXGN - Latest Insights

AXGN
Sep 10, 2026, 4:56 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $42.00
Real-time Price: $42.16 info
Change: +$0.160 (+0.38%) info
Market Cap: $2.267B info
AXGN
Sep 10, 2026, 4:55 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $42.04
Real-time Price: $42.16 info
Change: +$0.120 (+0.29%) info
Market Cap: $2.267B info
AXGN
Sep 10, 2026, 12:31 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $42.39
Real-time Price: $42.16 info
Change: -$0.225 (-0.53%) info
Market Cap: $2.267B info
AXGN
Sep 10, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $46.73
Real-time Price: $42.16 info
Change: -$4.57 (-10%) info
Market Cap: $2.267B info
AXGN
Sep 10, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $47.55
Real-time Price: $42.16 info
Change: -$5.39 (-11%) info
Market Cap: $2.267B info